Revenue Recognition

3 Months Ended

Mar. 31, 2024

Revenue from Contract With Customer [Abstract]

Revenue Recognition

12.Revenue Recognition

The following table provides information about disaggregated revenue by product and services:

	Three Months Ended March 31,
	2024		2023
Product sales, net	$	12,843	$	1,043
Processing and storage fees, net		1,287		1,357
License, royalty and other		551		1,535
Net revenues	$	14,681	$	3,935

The following table provides changes in deferred revenue from contract liabilities:

	2024			2023
Balance at January 1	$	6,020		$	4,492
Deferral of revenue*		1,307			1,195
Recognition of unearned revenue		(1,256	)		(1,163	)
Balance at March 31	$	6,071		$	4,524

* Deferral of revenue resulted from payments received in advance of performance under the biobanking services storage contracts that are recognized as revenue under the contract as performance is completed.